Baillie Gifford & Co
NBTX

Baillie Gifford & Co’s Nanobiotix NBTX Stock Holding History

Baillie Gifford & Co’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,869,030
Closed -$14.3M – 288
2024
Q2 		$14.3M Hold
2,869,030
– – 0.01% 195
2024
Q1 		$17.9M Hold
2,869,030
– – 0.01% 194
2023
Q4 		$20.9M Buy
2,869,030
+932,835
+48% +$5.91M 0.02% 188
2023
Q3 		$16.9M Buy
1,936,195
+536,195
+38% +$4.45M 0.02% 192
2023
Q2 		$7.25M Hold
1,400,000
– – 0.01% 231
2023
Q1 		$5.08M Hold
1,400,000
– – ﹤0.01% 240
2022
Q4 		$4.62M Hold
1,400,000
– – ﹤0.01% 246
2022
Q3 		$4.91M Hold
1,400,000
– – 0.01% 238
2022
Q2 		$5.39M Hold
1,400,000
– – 0.01% 230
2022
Q1 		$10.5M Hold
1,400,000
– – 0.01% 237
2021
Q4 		$11.6M Hold
1,400,000
– – 0.01% 241
2021
Q3 		$15.9M Hold
1,400,000
– – 0.01% 234
2021
Q2 		$19.3M Hold
1,400,000
– – 0.01% 231
2021
Q1 		$21M Hold
1,400,000
– – 0.01% 225
2020
Q4 		$23.1M Buy
+1,400,000
New +$24.1M 0.01% 194

Other funds holding NBTX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co's NBTX Position: Q3 2024 in Review

Baillie Gifford & Co sold out of Nanobiotix (NBTX) in Q3 2024, closing a stake of 2,869,030 shares — an estimated $14.3M sold.

Baillie Gifford & Co first reported a position in NBTX in Q4 2020 and held it in 15 quarters. The position peaked at $23.1M in Q4 2020. 10 funds tracked by Wall St. Rank hold NBTX as of Q3 2024.

  • Baillie Gifford & Co reported no remaining Nanobiotix position as of Q3 2024 after selling out during the quarter.
  • Baillie Gifford & Co sold 2,869,030 Nanobiotix shares in Q3 2024, an estimated $14.3M.
  • Baillie Gifford & Co first reported a position in Nanobiotix in Q4 2020 and held it in 15 quarters.
  • Baillie Gifford & Co's Nanobiotix position peaked at $23.1M in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Nanobiotix as of Q3 2024.

Based on Baillie Gifford & Co's 13F filing for Q3 2024, filed 5 Nov 2024.